Response to "letter concerning: Clewell (2019) incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene." (UIHT-2020-0053).
Saved in:
| Title: | Response to "letter concerning: Clewell (2019) incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene." (UIHT-2020-0053). |
|---|---|
| Authors: | Clewell HJ 3rd; Research Triangle Park, Ramboll US Corporation, Charlotte, North Carolina, USA., Campbell JL; Research Triangle Park, Ramboll US Corporation, Charlotte, North Carolina, USA., Van Landingham C; Ramboll US Corporation, Monroe, Louisiana, USA., Franzen A; Ramboll US Corporation, Monroe, Louisiana, USA., Yoon M; ToxStrategies, Inc., Cary, North Carolina, USA., Dodd DE; Research Triangle Park, The Hamner Institutes for Health Sciences, North Carolina, USA., Andersen ME; Research Triangle Park, The Hamner Institutes for Health Sciences, North Carolina, USA., Gentry PR; ToxStrategies, Inc., Cary, North Carolina, USA. |
| Source: | Inhalation toxicology [Inhal Toxicol] 2020 Aug; Vol. 32 (9-10), pp. 369-371. Date of Electronic Publication: 2020 Sep 08. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8910739 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-7691 (Electronic) Linking ISSN: 08958378 NLM ISO Abbreviation: Inhal Toxicol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
